Status:
UNKNOWN
TMS Treatment in Multiple System Atrophy With Fatigue
Lead Sponsor:
Xuanwu Hospital, Beijing
Conditions:
Transcranial Magnetic Stimulation
Multiple System Atrophy
Eligibility:
All Genders
30-75 years
Phase:
NA
Brief Summary
Transcranial magnetic stimulation (TMS) is a procedure that has been shown to improve fatigue in chronic sufferers. It uses a plastic covered coil that sends a magnetic pulse through the skull into th...
Eligibility Criteria
Inclusion
- Patients with Multiple system atrophy diagnosed as "possible" or "probable" according to the 2008 MDS clinical diagnostic criteria;
- Age ≥30Aged ≤ 75years old;
- right handedness
- MMSE\>24
- the dosage and species of anti-parkinson drug is maintained during the treatment;
- The patient or his/her legal guardian agreed to participate in the trial and signed the informed consent.Ability to follow research plans and visit plans.
- FSS≥4
Exclusion
- Serious medical and mental illness;
- History of stroke, intracranial tumor and other central nervous system;
- Patients with suicidal tendencies and psychotic symptoms.
- MRI for contraindications, such as metal implants, claustrophobia, etc
- Contraindications for TMS (such as history of seizures, pregnant women, installation of pacemakers, metal inclusions in the body, intracranial hypertension, severe bleeding tendency, etc.)
- Patients who received TMS treatment for nearly half a year.
Key Trial Info
Start Date :
October 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2022
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04313530
Start Date
October 1 2019
End Date
May 1 2022
Last Update
April 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Neurology Department of Xuanwu Hospital,Capital Medical University
Beijing, Beijing Municipality, China, 100053